Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herman Mielants

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Arthritis and Rheumatism|July 28, 2006
Classification criteria for psoriatic arthritis: development of new criteria from a large international studyWilliam Taylor, Dafna Gladman, Philip Helliwell, et al.
Rheumatology (Oxford, England)|April 3, 2012
Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction?Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados, et al.
Arthritis Care & Research|July 19, 2012
Quantitative assessment of foot structure in rheumatoid arthritis by a foot digitizer: detection of deformities even in the absence of erosionsSophie De Mits, Herman Mielants, Dirk De Clercq, et al.
Annals of the Rheumatic Diseases|October 13, 2011
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal studyAstrid van Tubergen, Sofia Ramiro, Désirée van der Heijde, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Rheumatology International|September 27, 2008
Clinical observations programme in SpA: disease parameters, treatment options and practical management issuesDirk Elewaut, Filip Van den Bosch, Gust Verbruggen, et al.
Rheumatic Diseases Clinics of North America|September 4, 2003
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulationFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis and Rheumatism|April 29, 2006
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritisJohn R Kirwan, Sarah H Hickey, Roger Hällgren, et al.
Drugs|November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitisFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis Research & Therapy|March 4, 2005
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathyDominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Arthritis and Rheumatism|July 28, 2006
Classification criteria for psoriatic arthritis: development of new criteria from a large international studyWilliam Taylor, Dafna Gladman, Philip Helliwell, et al.
Rheumatology (Oxford, England)|April 3, 2012
Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction?Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados, et al.
Arthritis Care & Research|July 19, 2012
Quantitative assessment of foot structure in rheumatoid arthritis by a foot digitizer: detection of deformities even in the absence of erosionsSophie De Mits, Herman Mielants, Dirk De Clercq, et al.
Annals of the Rheumatic Diseases|October 13, 2011
Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal studyAstrid van Tubergen, Sofia Ramiro, Désirée van der Heijde, et al.
Plos One|November 29, 2016
A Nationwide Survey on Patient's versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise StudySophie De Mits, Jan Lenaerts, Bert Vander Cruyssen, et al.
Rheumatology International|September 27, 2008
Clinical observations programme in SpA: disease parameters, treatment options and practical management issuesDirk Elewaut, Filip Van den Bosch, Gust Verbruggen, et al.
Rheumatic Diseases Clinics of North America|September 4, 2003
Infliximab in patients who have spondyloarthropathy: clinical efficacy, safety, and biological immunomodulationFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis and Rheumatism|April 29, 2006
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritisJohn R Kirwan, Sarah H Hickey, Roger Hällgren, et al.
Drugs|November 26, 2004
Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitisFilip De Keyser, Dominique Baeten, Filip Van den Bosch, et al.
Arthritis Research & Therapy|March 4, 2005
Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathyDominique Baeten, Elli Kruithof, Leen De Rycke, et al.
Pageof 6